Suita, Japan

Keizo Yoshida


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 60(Granted Patents)


Location History:

  • Ibaraki, JP (1981)
  • Suita, JP (1984 - 1987)
  • Osaka, JP (1997 - 1999)

Company Filing History:


Years Active: 1981-1999

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Keizo Yoshida: Innovator in Cerebrovascular Treatments

Introduction

Keizo Yoshida is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of cerebrovascular diseases. With a total of 8 patents to his name, Yoshida's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

Yoshida's latest patents focus on a medicament for treating or preventing cerebrovascular dementia. The compounds he has developed are 5-HT antagonists, which, when combined with pharmaceutically acceptable carriers or excipients, can be administered to both animals and humans. These compounds are particularly useful in treating or preventing cerebrovascular dementia, showcasing Yoshida's commitment to advancing medical science.

Career Highlights

Throughout his career, Keizo Yoshida has been associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his innovative ideas in a practical setting. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry.

Collaborations

Yoshida has collaborated with notable colleagues, including Masanobu Kohsaka and Hirokazu Tanaka. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the quality and impact of their collective work.

Conclusion

In summary, Keizo Yoshida is a dedicated inventor whose work in cerebrovascular treatments is paving the way for new medical advancements. His innovative approach and collaboration with esteemed colleagues highlight his significant role in the pharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…